[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

HK1037960A1 - Mmp inhibitors in connective tissue softening. - Google Patents

Mmp inhibitors in connective tissue softening.

Info

Publication number
HK1037960A1
HK1037960A1 HK01108013A HK01108013A HK1037960A1 HK 1037960 A1 HK1037960 A1 HK 1037960A1 HK 01108013 A HK01108013 A HK 01108013A HK 01108013 A HK01108013 A HK 01108013A HK 1037960 A1 HK1037960 A1 HK 1037960A1
Authority
HK
Hong Kong
Prior art keywords
connective tissue
mmp inhibitors
tissue softening
softening
connective
Prior art date
Application number
HK01108013A
Other languages
English (en)
Inventor
Mark William James Ferguson
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Publication of HK1037960A1 publication Critical patent/HK1037960A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Package Frames And Binding Bands (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK01108013A 1999-02-18 2001-11-14 Mmp inhibitors in connective tissue softening. HK1037960A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9903598.2A GB9903598D0 (en) 1999-02-18 1999-02-18 Connective tissue healing
PCT/GB2000/000474 WO2000048617A2 (en) 1999-02-18 2000-02-14 Connective tissue softening

Publications (1)

Publication Number Publication Date
HK1037960A1 true HK1037960A1 (en) 2002-03-01

Family

ID=10847938

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01108013A HK1037960A1 (en) 1999-02-18 2001-11-14 Mmp inhibitors in connective tissue softening.

Country Status (13)

Country Link
US (1) US6455569B1 (de)
EP (1) EP1152757B1 (de)
JP (1) JP2002537268A (de)
AT (1) ATE299703T1 (de)
AU (1) AU772470B2 (de)
CA (1) CA2362279C (de)
DE (1) DE60021350T2 (de)
DK (1) DK1152757T3 (de)
ES (1) ES2244410T3 (de)
GB (1) GB9903598D0 (de)
HK (1) HK1037960A1 (de)
PT (1) PT1152757E (de)
WO (1) WO2000048617A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436629B1 (en) * 2000-10-27 2002-08-20 The Regents Of The University Of California Modulating angiogenesis
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
US20070259030A1 (en) * 2006-05-05 2007-11-08 Drapeau Susan J Methods, systems and reagents for tendon and ligament therapy
US8247384B2 (en) 2006-11-15 2012-08-21 Coda Therapeutics, Inc. Methods and compositions for wound healing
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US20110130710A1 (en) * 2007-12-21 2011-06-02 David Lawrence Becker Treatment of abnormal or excessive scars
US9035037B2 (en) * 2007-12-21 2015-05-19 Coda Therapeutics, Inc. Medical devices
US20110217313A1 (en) * 2007-12-21 2011-09-08 Becker David L Treatment of orthopedic conditions
EP3183346B1 (de) 2014-08-22 2024-10-23 Auckland Uniservices Limited Kanalmodulator
WO2022128057A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for prevention and treatment of collagen degradation in human connecting tissue

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
US5239078A (en) * 1990-11-21 1993-08-24 Glycomed Incorporated Matrix metalloprotease inhibitors
US5318964A (en) 1992-06-11 1994-06-07 Hoffmann-La Roche Inc. Hydroxamic derivatives and pharmaceutical compositions
US5310759A (en) * 1992-08-12 1994-05-10 Bockman Richard S Methods of protecting and preserving connective and support tissues
WO1994022309A1 (en) * 1993-04-07 1994-10-13 Glycomed Incorporated Synthetic matrix metalloprotease inhibitors and uses thereof
GB9405076D0 (en) 1994-03-16 1994-04-27 Inst Of Ophtalmology A medical use of matrix metalloproteinase inhibitors
DE19542189A1 (de) * 1995-11-13 1997-05-15 Hoechst Ag Cyclische N-substituierte alpha-Iminohydroxamsäuren
RU2164914C2 (ru) * 1995-11-13 2001-04-10 Хехст Акциенгезелльшафт ЦИКЛИЧЕСКИЕ И ГЕТЕРОЦИКЛИЧЕСКИЕ N-ЗАМЕЩЕННЫЕ α-ИМИНОГИДРОКСАМОВЫЕ И КАРБОНОВЫЕ КИСЛОТЫ
GB9714936D0 (en) 1997-07-17 1997-09-17 Smith & Nephew Cell culture products

Also Published As

Publication number Publication date
JP2002537268A (ja) 2002-11-05
GB9903598D0 (en) 1999-04-07
CA2362279C (en) 2010-05-25
PT1152757E (pt) 2005-09-30
WO2000048617A2 (en) 2000-08-24
ATE299703T1 (de) 2005-08-15
DK1152757T3 (da) 2005-10-31
EP1152757B1 (de) 2005-07-20
US6455569B1 (en) 2002-09-24
ES2244410T3 (es) 2005-12-16
WO2000048617A3 (en) 2001-02-08
CA2362279A1 (en) 2000-08-24
EP1152757A2 (de) 2001-11-14
DE60021350T2 (de) 2006-04-27
AU772470B2 (en) 2004-04-29
DE60021350D1 (de) 2005-08-25
AU2557100A (en) 2000-09-04

Similar Documents

Publication Publication Date Title
MY135732A (en) 5,6-trimethylenepyrimidin - 4 - one compounds
WO2002010348A3 (en) Tissue implant for cartilage repair
AU2713600A (en) Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
EE04221B1 (et) Östrogeeni kasutamine ravimi valmistamiseks füüsiliste seisundite raviks menopausijärgsetel isikutel
BR9916484A (pt) Combinações de inibidores do transporte de ácido biliar ileal e de agentes sequestrantes de ácido biliar em indicações cardiovasculares
TR200103216T2 (tr) Pirimidinon bileşimleri
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
BR0315090A (pt) Processo para fazer um produto polimérico, disco espinal artificial, implante cirúrgico, aparelho para fazer um produto polimérico, e, utilização do processo
AU5596298A (en) Integrin antagonists
BR9913705A (pt) Métodos de tratamento de mieloma múltiplo e reabsorção de tecido ósseo induzido por mieloma utilizando antagonistas de integrin
HK1037960A1 (en) Mmp inhibitors in connective tissue softening.
WO2004024009A8 (en) Bone plates
HK1047707A1 (zh) (+)-曲馬朵、o-去甲曲馬朵或(+)-o-去甲曲馬朵、o-去甲-n-單-去甲-曲馬朵或(+)-o-去甲-n-單-去甲-曲馬朵治療尿失禁的用途
SG117434A1 (en) Use of alpha1beta1 integrin receptor inhibitors and tgf-beta1 inhibitors in the treatment of kidney disease
MXPA04004372A (es) Derivados heterociclicos de glicinamida y su uso medico.
AU5396199A (en) Bone fixation apparatus and method
MX9709910A (es) Compuestos que contienen arginina e imitaciones de arginina, su uso y composiciones que los contienen.
ATE543451T1 (de) Bioabsorbierbare, osteogenetische knochenplatte
TR200200278T2 (tr) Kalsilitik bileşimler
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
ATE284711T1 (de) Heilmittel und/oder prophylactische mittel zur behandlung von nervensystem-störungen
MXPA02004699A (es) Derivados de acidos hidroxieicosatetraenoico modificados con cadena omega y metodos de su uso para el tratameinto del ojo reseco.
ZA966577B (en) Pharmaceutical composition.
BR0112460A (pt) Método para tratamento de sépsis
DE69909395D1 (de) Zusammensetzung mit ketanserin und carnitin zur behandlung von crps

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120214